Skip to main content
Erschienen in: Current Reviews in Musculoskeletal Medicine 4/2020

19.06.2020 | Updates In Spine Surgery—Techniques, Biologics, and Non-Operative Management (W Hsu, Section Editor)

Ceramic Biologics for Bony Fusion—a Journey from First to Third Generations

verfasst von: Brandon Ortega, Carson Gardner, Sidney Roberts, Andrew Chung, Jeffrey C. Wang, Zorica Buser

Erschienen in: Current Reviews in Musculoskeletal Medicine | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To provide information on characteristics and use of various ceramics in spine fusion and future directions.

Recent Findings

In most recent years, focus has been shifted to the use of ceramics in minimally invasive surgeries or implementation of nanostructured surface modification features to promote osteoinductive properties. In addition, effort has been placed on the development of bioactive synthetics. Core characteristic of bioactive synthetics is that they undergo change to simulate a beneficial response within the bone. This change is based on chemical reaction and various chemical elements present in the bioactive ceramics. Recently, a synthetic 15-amino acid polypeptide bound to an anorganic bone material which mimics the cell-binding domain of type-I collagen opened a possibility for osteogenic and osteoinductive roles of this hybrid graft material.

Summary

Ceramics have been present in the spine fusion arena for several decades; however, their use has been limited. The major obstacle in published literature is small sample size resulting in low evidence and a potential for bias. In addition, different physical and chemical properties of various ceramics further contribute to the limited evidence. Although ceramics have several disadvantages, they still hold a great promise as a value-based graft material with being easily available, relatively inexpensive, and non-immunogenic.
Literatur
2.
Zurück zum Zitat John J, Mirahmadizadeh A, Seifi A. Association of insurance status and spinal fusion usage in the United States during two decades. J Clin Neurosci. 2018;51:80–4.CrossRef John J, Mirahmadizadeh A, Seifi A. Association of insurance status and spinal fusion usage in the United States during two decades. J Clin Neurosci. 2018;51:80–4.CrossRef
3.
Zurück zum Zitat Gruskay JA, Basques BA, Bohl DD, Webb ML, Grauer JN. Short-term adverse events, length of stay, and readmission after iliac crest bone graft for spinal fusion. Spine. 2014;39(20):1718–24.CrossRef Gruskay JA, Basques BA, Bohl DD, Webb ML, Grauer JN. Short-term adverse events, length of stay, and readmission after iliac crest bone graft for spinal fusion. Spine. 2014;39(20):1718–24.CrossRef
4.
Zurück zum Zitat Tay BK, Patel VV, Bradford DS. Calcium sulfate and calcium phosphate-based bone substitutes. Mimicry of the mineral phase of bone. Orthop Clin North Am. 1999;30:615–23.CrossRef Tay BK, Patel VV, Bradford DS. Calcium sulfate and calcium phosphate-based bone substitutes. Mimicry of the mineral phase of bone. Orthop Clin North Am. 1999;30:615–23.CrossRef
5.
Zurück zum Zitat Vaz K, Verma K, Protopsaltis T, Schwab F, Lonner B, Errico T. Bone grafting options for lumbar spine surgery: a review examining clinical efficacy and complications. SAS J. 2010;4(3):75–86.CrossRef Vaz K, Verma K, Protopsaltis T, Schwab F, Lonner B, Errico T. Bone grafting options for lumbar spine surgery: a review examining clinical efficacy and complications. SAS J. 2010;4(3):75–86.CrossRef
6.
Zurück zum Zitat Khan SN, Fraser JF, Sandhu HS, Cammisa FP Jr, Girardi FP, Lane JM. Use of osteopromotive growth factors, demineralized bone matrix, and ceramics to enhance spinal fusion. J Am Acad Orthop Surg. 2005;13(2):129–37.CrossRef Khan SN, Fraser JF, Sandhu HS, Cammisa FP Jr, Girardi FP, Lane JM. Use of osteopromotive growth factors, demineralized bone matrix, and ceramics to enhance spinal fusion. J Am Acad Orthop Surg. 2005;13(2):129–37.CrossRef
7.
Zurück zum Zitat Cook RW, Hsu WK. Ceramics: clinical evidence for ceramics in spine fusion. Semin Spine Surgery. 2016;28(4):217–25.CrossRef Cook RW, Hsu WK. Ceramics: clinical evidence for ceramics in spine fusion. Semin Spine Surgery. 2016;28(4):217–25.CrossRef
8.
Zurück zum Zitat • Korovessis P, Koureas G, Zacharatos S, Papazisis Z, Lambiris E. Correlative radiological, self-assessment and clinical analysis of evolution in instrumented dorsal and lateral fusion for degenerative lumbar spine disease. Autograft versus coralline hydroxyapatite. Eur Spine J. 2005;14:630–8 An RCT comparing HA + local bone + BMA to ICBG in 60 patients undergoing posterior lumbar fusion. In HA groups, fusion was observed within the decorticated laminae but not intertransverse. Some of the major risks of bias included lack of randomization and differences in baseline characteristics among groups. CrossRef • Korovessis P, Koureas G, Zacharatos S, Papazisis Z, Lambiris E. Correlative radiological, self-assessment and clinical analysis of evolution in instrumented dorsal and lateral fusion for degenerative lumbar spine disease. Autograft versus coralline hydroxyapatite. Eur Spine J. 2005;14:630–8 An RCT comparing HA + local bone + BMA to ICBG in 60 patients undergoing posterior lumbar fusion. In HA groups, fusion was observed within the decorticated laminae but not intertransverse. Some of the major risks of bias included lack of randomization and differences in baseline characteristics among groups. CrossRef
9.
Zurück zum Zitat Yoshii T, Yuasa M, Sotome S, Yamada T, Sakaki K, Hirai T, et al. Porous/dense composite hydroxyapatite for anterior cervical discectomy and fusion. Spine. 2013;38(10):833–40.CrossRef Yoshii T, Yuasa M, Sotome S, Yamada T, Sakaki K, Hirai T, et al. Porous/dense composite hydroxyapatite for anterior cervical discectomy and fusion. Spine. 2013;38(10):833–40.CrossRef
10.
Zurück zum Zitat Lee JH, Hwang CJ, Song BW, Koo KH, Chang BS, Lee CK. A prospective consecutive study of instrumented posterolateral lumbar fusion using synthetic hydroxyapatite (Bongros-HA) as a bone graft extender. J Biomed Mater Res A. 2009;90(3):804–10.CrossRef Lee JH, Hwang CJ, Song BW, Koo KH, Chang BS, Lee CK. A prospective consecutive study of instrumented posterolateral lumbar fusion using synthetic hydroxyapatite (Bongros-HA) as a bone graft extender. J Biomed Mater Res A. 2009;90(3):804–10.CrossRef
11.
Zurück zum Zitat Nickoli MS, Hsu WK. Ceramic-based bone grafts as a bone grafts extender for lumbar spine arthrodesis: a systematic review. Glob Spine J. 2014;4(3):211–6.CrossRef Nickoli MS, Hsu WK. Ceramic-based bone grafts as a bone grafts extender for lumbar spine arthrodesis: a systematic review. Glob Spine J. 2014;4(3):211–6.CrossRef
12.
Zurück zum Zitat Garin C, Boutrand S. Natural hydroxyapatite as a bone graft extender for posterolateral spine arthrodesis. Int Orthop. 2016;19. Garin C, Boutrand S. Natural hydroxyapatite as a bone graft extender for posterolateral spine arthrodesis. Int Orthop. 2016;19.
13.
Zurück zum Zitat Yoo JS, Min SH, Yoon SH. Fusion rate according to mixture ratio and volumes of bone graft in minimally invasive transforaminal lumbar interbody fusion: minimum 2-year follow-up. Eur J Orthop Surg Traumatol. 2015;25:183–9.CrossRef Yoo JS, Min SH, Yoon SH. Fusion rate according to mixture ratio and volumes of bone graft in minimally invasive transforaminal lumbar interbody fusion: minimum 2-year follow-up. Eur J Orthop Surg Traumatol. 2015;25:183–9.CrossRef
14.
Zurück zum Zitat Brandoff JF, Silber JS, Vaccaro AR. Contemporary alternatives to synthetic bone grafts for spine surgery. Am J Orthop. 2008;37:410–4.PubMed Brandoff JF, Silber JS, Vaccaro AR. Contemporary alternatives to synthetic bone grafts for spine surgery. Am J Orthop. 2008;37:410–4.PubMed
15.
Zurück zum Zitat Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop. 1981;157:259–78. Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop. 1981;157:259–78.
16.
Zurück zum Zitat Dai LY, Jiang LS. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up. Spine. 2008;33(12):1299–304.CrossRef Dai LY, Jiang LS. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up. Spine. 2008;33(12):1299–304.CrossRef
17.
Zurück zum Zitat Gan Y, Dai K, Zhang P, Tang T, Zhu Z, Lu J. The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion. Biomaterials. 2008;29:3973–82.CrossRef Gan Y, Dai K, Zhang P, Tang T, Zhu Z, Lu J. The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion. Biomaterials. 2008;29:3973–82.CrossRef
18.
Zurück zum Zitat Abbasi H, Miller L, Abbasi A, Orandi V, Khaghany K. Minimally invasive scoliosis surgery with oblique lateral lumbar interbody fusion: single surgeon feasibility study. Cureus. 2017;9(6):e1389.PubMedPubMedCentral Abbasi H, Miller L, Abbasi A, Orandi V, Khaghany K. Minimally invasive scoliosis surgery with oblique lateral lumbar interbody fusion: single surgeon feasibility study. Cureus. 2017;9(6):e1389.PubMedPubMedCentral
19.
Zurück zum Zitat • Parker RM, Malham GM. Comparison of a calcium phosphate bone substitute with recombinant human bone morphogenetic protein-2: a prospective study of fusion rates, clinical outcomes and complications with 24-month follow-up. Eur Spine J. 2017;26(3):754–63 Patients undergoing XLIF with β-TCP or rhBMP-2. In patients with addition of posterior fusion, fusion rates were similar between the groups. In standalone XLIF patients, rhBMP-2 had higher fusion rates. There was a difference in number of patients between the groups. CrossRef • Parker RM, Malham GM. Comparison of a calcium phosphate bone substitute with recombinant human bone morphogenetic protein-2: a prospective study of fusion rates, clinical outcomes and complications with 24-month follow-up. Eur Spine J. 2017;26(3):754–63 Patients undergoing XLIF with β-TCP or rhBMP-2. In patients with addition of posterior fusion, fusion rates were similar between the groups. In standalone XLIF patients, rhBMP-2 had higher fusion rates. There was a difference in number of patients between the groups. CrossRef
20.
Zurück zum Zitat Malham GM, Ellis NJ, Parker RM, Blecher CM, White R, Goss B, et al. Maintenance of segmental lordosis and disk height in stand-alone and instrumented extreme lateral interbody fusion (XLIF). Clin Spine Surg. 2017;30(2):E90–8.CrossRef Malham GM, Ellis NJ, Parker RM, Blecher CM, White R, Goss B, et al. Maintenance of segmental lordosis and disk height in stand-alone and instrumented extreme lateral interbody fusion (XLIF). Clin Spine Surg. 2017;30(2):E90–8.CrossRef
23.
Zurück zum Zitat • Buser Z, Brodke DS, Youssef JA, Meisel HJ, Myhre SL, Hashimoto R, et al. Synthetic bone graft versus autograft or allograft for spinal fusion: a systematic review. J Neurosurg. 2016;25(4):509–16. https://doi.org/10.3171/2016.1.SPINE151005A systematic review of various ceramics for cervical and lumbar fusion. Overall evidence was low due to the high risk of bias and small sample sizes in both lumbar and cervical studies. CrossRef • Buser Z, Brodke DS, Youssef JA, Meisel HJ, Myhre SL, Hashimoto R, et al. Synthetic bone graft versus autograft or allograft for spinal fusion: a systematic review. J Neurosurg. 2016;25(4):509–16. https://​doi.​org/​10.​3171/​2016.​1.​SPINE151005A systematic review of various ceramics for cervical and lumbar fusion. Overall evidence was low due to the high risk of bias and small sample sizes in both lumbar and cervical studies. CrossRef
25.
Zurück zum Zitat Liao J, Chen W, Wang H. Treatment of thoracolumbar burst fractures by short-segment pedicle screw fixation using a combination of two additional pedicle screws and vertebroplasty at the level of the fracture: a finite element analysis. BMC Musculoskelet Disord. 2017;18:262(18). https://doi.org/10.1186/s12891-017-1623-0.CrossRef Liao J, Chen W, Wang H. Treatment of thoracolumbar burst fractures by short-segment pedicle screw fixation using a combination of two additional pedicle screws and vertebroplasty at the level of the fracture: a finite element analysis. BMC Musculoskelet Disord. 2017;18:262(18). https://​doi.​org/​10.​1186/​s12891-017-1623-0.CrossRef
39.
Zurück zum Zitat Nagineni VV, James AR, Alimi M, Hofstetter C, Shin BJ, Njoku I Jr, et al. Silicate-substituted calcium phosphate ceramic bone graft replacement for spinal fusion procedures. Spine (Phila Pa 1976). 2012;37:E1264–72.CrossRef Nagineni VV, James AR, Alimi M, Hofstetter C, Shin BJ, Njoku I Jr, et al. Silicate-substituted calcium phosphate ceramic bone graft replacement for spinal fusion procedures. Spine (Phila Pa 1976). 2012;37:E1264–72.CrossRef
40.
Zurück zum Zitat Wheeler DL, Jenis LG, Kovach ME, Marini J, Turner AS. Efficacy of silicated calcium phosphate graft in posterolateral lumbar fusion in sheep. Spine J. 2007;7:308–17.CrossRef Wheeler DL, Jenis LG, Kovach ME, Marini J, Turner AS. Efficacy of silicated calcium phosphate graft in posterolateral lumbar fusion in sheep. Spine J. 2007;7:308–17.CrossRef
41.
Zurück zum Zitat Carlisle EM. Silicon: a possible factor in bone calcification. Science. 1970;167:279–80.CrossRef Carlisle EM. Silicon: a possible factor in bone calcification. Science. 1970;167:279–80.CrossRef
42.
Zurück zum Zitat Cameron K, Travers P, Chander C, Buckland T, Campion C, Noble B. Directed osteogenic differentiation of human mesenchymal stem/precursor cells on silicate substituted calcium phosphate. J Biomed Mater Res A. 2013;101:13–22.CrossRef Cameron K, Travers P, Chander C, Buckland T, Campion C, Noble B. Directed osteogenic differentiation of human mesenchymal stem/precursor cells on silicate substituted calcium phosphate. J Biomed Mater Res A. 2013;101:13–22.CrossRef
43.
Zurück zum Zitat Jenis LG, Banco RJ. Efficacy of silicate-substituted calcium phosphate ceramic in posterolateral instrumented lumbar fusion. Spine (Phila Pa 1976). 2010;35:E1058–63.CrossRef Jenis LG, Banco RJ. Efficacy of silicate-substituted calcium phosphate ceramic in posterolateral instrumented lumbar fusion. Spine (Phila Pa 1976). 2010;35:E1058–63.CrossRef
44.
Zurück zum Zitat Alimi M, Navarro-Ramirez R, Parikh K, Njoku I, Hofstetter CP, Tsiouris AJ, et al. Radiographic and clinical outcome of silicate-substituted calcium phosphate (Si-CaP) ceramic bone graft in spinal fusion procedures. Clin Spine Surg. 2017;30:E845–E52.CrossRef Alimi M, Navarro-Ramirez R, Parikh K, Njoku I, Hofstetter CP, Tsiouris AJ, et al. Radiographic and clinical outcome of silicate-substituted calcium phosphate (Si-CaP) ceramic bone graft in spinal fusion procedures. Clin Spine Surg. 2017;30:E845–E52.CrossRef
45.
Zurück zum Zitat Licina P, Coughlan M, Johnston E, Pearcy M. Comparison of silicate-substituted calcium phosphate (Actifuse) with recombinant human bone morphogenetic protein-2 (infuse) in posterolateral instrumented lumbar fusion. Glob Spine J. 2015;5:471–8.CrossRef Licina P, Coughlan M, Johnston E, Pearcy M. Comparison of silicate-substituted calcium phosphate (Actifuse) with recombinant human bone morphogenetic protein-2 (infuse) in posterolateral instrumented lumbar fusion. Glob Spine J. 2015;5:471–8.CrossRef
46.
Zurück zum Zitat Pimenta L, Marchi L, Oliveira L, Coutinho E, Amaral R. A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2. J Neurol Surg A Cent Eur Neurosurg. 2013;74:343–50.CrossRef Pimenta L, Marchi L, Oliveira L, Coutinho E, Amaral R. A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2. J Neurol Surg A Cent Eur Neurosurg. 2013;74:343–50.CrossRef
47.
Zurück zum Zitat Mokawem M, Katzouraki G, Harman CL, Lee R. Lumbar interbody fusion rates with 3D-printed lamellar titanium cages using a silicate-substituted calcium phosphate bone graft. J Clin Neurosci. 2019;68:134–9.CrossRef Mokawem M, Katzouraki G, Harman CL, Lee R. Lumbar interbody fusion rates with 3D-printed lamellar titanium cages using a silicate-substituted calcium phosphate bone graft. J Clin Neurosci. 2019;68:134–9.CrossRef
48.
Zurück zum Zitat Bolger C, Jones D, Czop S. Evaluation of an increased strut porosity silicate-substituted calcium phosphate, SiCaP EP, as a synthetic bone graft substitute in spinal fusion surgery: a prospective, open-label study. Eur Spine J. 2019;28:1733–42.CrossRef Bolger C, Jones D, Czop S. Evaluation of an increased strut porosity silicate-substituted calcium phosphate, SiCaP EP, as a synthetic bone graft substitute in spinal fusion surgery: a prospective, open-label study. Eur Spine J. 2019;28:1733–42.CrossRef
49.
Zurück zum Zitat Lerner T, Liljenqvist U. Silicate-substituted calcium phosphate as a bone graft substitute in surgery for adolescent idiopathic scoliosis. Eur Spine J. 2013;22(Suppl 2):S185–94.CrossRef Lerner T, Liljenqvist U. Silicate-substituted calcium phosphate as a bone graft substitute in surgery for adolescent idiopathic scoliosis. Eur Spine J. 2013;22(Suppl 2):S185–94.CrossRef
50.
Zurück zum Zitat Jones JR. Review of bioactive glass: from Hench to hybrids. Acta Biomater. 2013;9:4457–86.CrossRef Jones JR. Review of bioactive glass: from Hench to hybrids. Acta Biomater. 2013;9:4457–86.CrossRef
51.
Zurück zum Zitat Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res. 2001;55:151–7.CrossRef Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res. 2001;55:151–7.CrossRef
52.
Zurück zum Zitat Kaufmann EA, Ducheyne P, Shapiro IM. Effect of varying physical properties of porous, surface modified bioactive glass 45S5 on osteoblast proliferation and maturation. J Biomed Mater Res. 2000;52:783–96.CrossRef Kaufmann EA, Ducheyne P, Shapiro IM. Effect of varying physical properties of porous, surface modified bioactive glass 45S5 on osteoblast proliferation and maturation. J Biomed Mater Res. 2000;52:783–96.CrossRef
53.
Zurück zum Zitat Lindfors NC, Tallroth K, Aho AJ. Bioactive glass as bone-graft substitute for posterior spinal fusion in rabbit. J Biomed Mater Res. 2002;63:237–44.CrossRef Lindfors NC, Tallroth K, Aho AJ. Bioactive glass as bone-graft substitute for posterior spinal fusion in rabbit. J Biomed Mater Res. 2002;63:237–44.CrossRef
54.
Zurück zum Zitat Bergman SALL. Bone in-fill of non-healing calvarial defects using particulate bioglass and autogenous bone. Bioceramics. 1995;8:17–21. Bergman SALL. Bone in-fill of non-healing calvarial defects using particulate bioglass and autogenous bone. Bioceramics. 1995;8:17–21.
55.
Zurück zum Zitat BW C. The use of Bioglass for spinal arthrodesis and iliac crest repair-an in vivo sheep model. In I O ed. Proceedings of the North American Spine Society, Annual Meeting, San Francisco, CA, October 28–31.: Elsevier Science, 1998:214–6. BW C. The use of Bioglass for spinal arthrodesis and iliac crest repair-an in vivo sheep model. In I O ed. Proceedings of the North American Spine Society, Annual Meeting, San Francisco, CA, October 28–31.: Elsevier Science, 1998:214–6.
56.
Zurück zum Zitat Ilharreborde B, Morel E, Fitoussi F, Presedo A, Souchet P, Penneçot GF, et al. Bioactive glass as a bone substitute for spinal fusion in adolescent idiopathic scoliosis: a comparative study with iliac crest autograft. J Pediatr Orthop. 2008;28:347–51.CrossRef Ilharreborde B, Morel E, Fitoussi F, Presedo A, Souchet P, Penneçot GF, et al. Bioactive glass as a bone substitute for spinal fusion in adolescent idiopathic scoliosis: a comparative study with iliac crest autograft. J Pediatr Orthop. 2008;28:347–51.CrossRef
57.
Zurück zum Zitat Frantzén J, Rantakokko J, Aro HT, Heinänen J, Kajander S, Gullichsen E, et al. Instrumented spondylodesis in degenerative spondylolisthesis with bioactive glass and autologous bone: a prospective 11-year follow-up. J Spinal Disord Tech. 2011;24:455–61.CrossRef Frantzén J, Rantakokko J, Aro HT, Heinänen J, Kajander S, Gullichsen E, et al. Instrumented spondylodesis in degenerative spondylolisthesis with bioactive glass and autologous bone: a prospective 11-year follow-up. J Spinal Disord Tech. 2011;24:455–61.CrossRef
58.
Zurück zum Zitat Barrey C, Broussolle T. Clinical and radiographic evaluation of bioactive glass in posterior cervical and lumbar spinal fusion. Eur J Orthop Surg Traumatol. 2019;29:1623–9.CrossRef Barrey C, Broussolle T. Clinical and radiographic evaluation of bioactive glass in posterior cervical and lumbar spinal fusion. Eur J Orthop Surg Traumatol. 2019;29:1623–9.CrossRef
59.
Zurück zum Zitat Sherman BP, Lindley EM, Turner AS, Seim HB 3rd, Benedict J, Burger EL, et al. Evaluation of ABM/P-15 versus autogenous bone in an ovine lumbar interbody fusion model. Eur Spine J Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res Soc. 2010;19(12):2156–63. https://doi.org/10.1007/s00586-010-1546-z.CrossRef Sherman BP, Lindley EM, Turner AS, Seim HB 3rd, Benedict J, Burger EL, et al. Evaluation of ABM/P-15 versus autogenous bone in an ovine lumbar interbody fusion model. Eur Spine J Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res Soc. 2010;19(12):2156–63. https://​doi.​org/​10.​1007/​s00586-010-1546-z.CrossRef
61.
Zurück zum Zitat Arnold PM, Sasso RC, Janssen ME, Fehlings MG, Smucker JD, Vaccaro AR, et al. Efficacy of i-factor bone graft versus autograft in anterior cervical discectomy and fusion: results of the prospective, randomized, single-blinded Food and Drug Administration investigational device exemption study. Spine. 2016;41(13):1075–83. https://doi.org/10.1097/BRS.0000000000001466.CrossRefPubMed Arnold PM, Sasso RC, Janssen ME, Fehlings MG, Smucker JD, Vaccaro AR, et al. Efficacy of i-factor bone graft versus autograft in anterior cervical discectomy and fusion: results of the prospective, randomized, single-blinded Food and Drug Administration investigational device exemption study. Spine. 2016;41(13):1075–83. https://​doi.​org/​10.​1097/​BRS.​0000000000001466​.CrossRefPubMed
62.
Zurück zum Zitat Arnold PM, Sasso RC, Janssen ME, Fehlings MG, Heary RF, Vaccaro AR, et al. i-FactorTM bone graft vs autograft in anterior cervical discectomy and fusion: 2-year follow-up of the randomized single-blinded Food and Drug Administration investigational device exemption study. Neurosurgery. 2018;83(3):377–84. https://doi.org/10.1093/neuros/nyx432.CrossRefPubMed Arnold PM, Sasso RC, Janssen ME, Fehlings MG, Heary RF, Vaccaro AR, et al. i-FactorTM bone graft vs autograft in anterior cervical discectomy and fusion: 2-year follow-up of the randomized single-blinded Food and Drug Administration investigational device exemption study. Neurosurgery. 2018;83(3):377–84. https://​doi.​org/​10.​1093/​neuros/​nyx432.CrossRefPubMed
Metadaten
Titel
Ceramic Biologics for Bony Fusion—a Journey from First to Third Generations
verfasst von
Brandon Ortega
Carson Gardner
Sidney Roberts
Andrew Chung
Jeffrey C. Wang
Zorica Buser
Publikationsdatum
19.06.2020
Verlag
Springer US
Erschienen in
Current Reviews in Musculoskeletal Medicine / Ausgabe 4/2020
Elektronische ISSN: 1935-9748
DOI
https://doi.org/10.1007/s12178-020-09651-x

Weitere Artikel der Ausgabe 4/2020

Current Reviews in Musculoskeletal Medicine 4/2020 Zur Ausgabe

Reverse Shoulder Arthroplasty (C Chambers and E Craig, Section Editors)

Hemiarthroplasty and Total Shoulder Arthroplasty Conversion to Reverse Total Shoulder Arthroplasty

Non-Operative Management of Anterior Knee Pain (M Fredericson and T Besier, Section Editors)

Taping, Bracing, and Injection Treatment for Patellofemoral Pain and Patellar Tendinopathy

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.